trending Market Intelligence /marketintelligence/en/news-insights/trending/apoc67oborfdy-iisn1hyg2 content esgSubNav
In This List

Adverum names interim CEO to permanent post

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery


Adverum names interim CEO to permanent post

Adverum Biotechnologies Inc. promoted Leone Patterson to the position of president and CEO.

Patterson was also named to the company's board.

According to an Oct. 17 news release, Patterson joined the company in June 2016 as CFO and had been serving as interim president and CEO since May. She will continue to serve as CFO until a replacement is appointed.

Adverum, a clinical-stage gene therapy company, focuses on unmet medical needs in serious rare and ocular diseases.